Misbranded performance-drug seller ordered to forfeit $180,000
Oct 4, 2026 edition · GC-2026-0206 · Published 2026-10-04 · Version 2 · Final
DOJ reported one year of probation and $180,000 forfeiture for Skyler Garman’s misbranded-drug and money-laundering conspiracies.
What happened
A September 30, 2026 DOJ announcement reports that Skyler Garman was sentenced to one year of probation for conspiracy involving distribution of misbranded drugs and conspiracy to commit money laundering. The court also ordered $180,000 forfeited as proceeds of the offenses. Garman admitted unlawful interstate distribution of selective androgen and estrogen receptor modulators from 2019–2021. The $180,000 forfeiture is distinct from the business's sales volume and is not described as a restitution award or a regulatory civil penalty.
Garman used Body Science Supplements and related Savior Research brands to sell products, largely unapproved or misbranded drugs, totaling more than $2.2 million. DOJ describes labels stating not for human consumption despite advice to customers on dosing and performance-enhancing use. The proceeds moved through business and personal accounts, with net profit over $180,000. The mismatch between the label and actual marketing is central: research-use wording did not establish lawful human-use distribution. The source addresses SARMs and SERMs in this scheme; it does not establish that every supplement or every drug in those broad classes is unlawful.
Scope and timing
- Authority status
- Final
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal
Why it matters
Supplier labels need comparison with the product’s regulatory status and actual marketing, particularly when dosing advice contradicts a research-use disclaimer.
Recommended action
Review supplier authorization, labeling and promotional claims before purchasing or recommending relevant products, and preserve evidence of actual intended use.
Case details
- agencies
- U.S. Department of Justice
- entities
- Skyler Garman, Body Science Supplements
- action Type
- Criminal resolution
- event Date
- 2026-09-30
- alleged Conduct
- Distribution of misbranded performance drugs and laundering proceeds.
- resolution
- September 30 announcement reports one year probation and $180,000 forfeiture as offense proceeds; separate business sales exceeded $2.2 million.
Operational lessons
- Review supplier authorization, product labeling and promotional claims before purchasing or recommending performance or weight-management products.
Sources
- Misbranded performance-drug seller ordered to forfeit $180,000Official · U.S. Department of Justice · 2026-09-30 · Source review 2026-10-05
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Enforcement Briefing report →